Efficacy of the epicutaneous immunotherapy for food allergy -Selection of skin sticking device and allergen
Not Applicable
- Conditions
- milk allergy
- Registration Number
- JPRN-UMIN000037562
- Lead Sponsor
- Tokai University Hachioji Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are adrenalin contraindications Patients with serious systemic diseases such as immunodeficiency, severe heart disease, chronic infection, and malignancy Others who are deemed inappropriate by the research leader or co-worker
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of intake of milk in oral food challenge within 4 weeks after 12 weeks of epicutaneous immunotherapy
- Secondary Outcome Measures
Name Time Method Safety of epicutaneous immunotherapy (evaluation of side reaction)